Rajiv Gulati has over 30 years of experience in the pharmaceutical industry and has been an independent consultant since 2015. Most recently, he served as President of Global Pharmaceutical Business at Ranbaxy. Prior to that, Rajiv spent several years at Eli Lilly & Company in various roles globally and in India, including as Senior Director of Global Anti-counterfeiting Operations, Director for India-China Strategy and Corporate Strategic Planning, as well as CMD in India overseeing performance in India, Nepal, Bhutan, Sri Lanka and Maldives.
He is an advisor to Multiples in the Pharmaceutical space, working with the team to source and diligence deals in this sector. He has been closely involved in several deals that Multiples has evaluated including in Encube Ethicals, one of Multiples’ portfolio companies.